Rainbow Children’s Medicare Limited has declared a final dividend of ₹3.5 per share for the fiscal year ended March 31, 2026, subject to shareholder approval. Alongside the financial results, the board has approved the re-appointment of key leadership figures, including the Chairman and Managing Director, Whole Time Director, and two Independent Directors, each for a five-year term. The company also scheduled its 28th Annual General Meeting for July 29, 2026.
Financial Performance and Dividend
Following the conclusion of the financial year ended March 31, 2026, the Board of Directors has reviewed and approved the audited standalone and consolidated financial results. Reflecting on the year’s performance, the company has recommended a final dividend of ₹3.5 per equity share, representing a 35% payout on the face value of ₹10 per share. This dividend is pending approval at the upcoming 28th Annual General Meeting.
Strategic Leadership Appointments
The Board has reinforced its leadership structure by approving several re-appointments for a new five-year term effective from August 2026 to August 2031. Dr. Ramesh Kancharla continues his tenure as Chairman and Managing Director, while Dr. Dinesh Kumar Chirla has been re-appointed as Whole Time Director. Additionally, the Board has extended the terms of Independent Directors Mr. Santanu Mukherjee and Ms. Sundari R. Pisupati, ensuring continuity in corporate governance.
Operational Updates and AGM Schedule
The company has set July 21, 2026, as the Record Date to determine shareholder eligibility for the dividend payout and participation in the 28th Annual General Meeting. The meeting is scheduled for July 29, 2026, and will be conducted via video conferencing to facilitate widespread shareholder attendance. Furthermore, M/s. Lavanya & Associates LLP has been re-appointed as the Cost Auditor for the financial year 2026-27, underscoring the company’s commitment to maintaining rigorous financial oversight.
Source: BSE
